| answer text |
<p>The Department is aware of the intermittent issues affecting the supply of Pneumococcal
polysaccharide 23-valent vaccine (PPV 23 vaccine). We are working closely with Public
Health England (PHE) and the supplier, MSD, on this issue and can confirm that further
United Kingdom deliveries are expected to be made available over the coming months.
Despite this, supplies are expected to be constrained for the foreseeable future.
In order to mitigate the impact to patients, PHE has issued clinical guidance to general
practitioners, which provides recommendations on how to manage patients who are eligible
for vaccination during periods of constraint.</p>
|
 |
